Community/Retail

Sponsored by ASHP and the ASHP Research and Education Foundation, the award honors student members in their second through fourth professional years of pharmacy school.

The FDA has approved baricitinib (Olumiant), a once-daily oral drug for adults with moderately-to-severely active rheumatoid arthritis.

An extension trial assesses the efficacy and safety of extending edaravone treatment past the FDA-approved 6 cycles.

Our team is on site in Denver all week covering from ASHP Summer 2018.

Studies explore the efficacy and safety of anticoagulation for atrial fibrillation in hemodialysis.

When individuals who are at risk for HIV use PrEP, and use it appropriately, risk of infection is significantly lowered.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

What role do pharmacists play in medication optimization to help save money?

New policies that aim to help generic drug makers move their products through the development and approval processes more efficiently have been announced by FDA Commissioner Scott Gottlieb, MD.

Pharmacy Times, the leading media resource for pharmacists and the pharmacy industry, and Specialty Pharmacy Times, the most read publication among specialty pharmacists, have been honored with the 2018 Hermes Creative Awards.

Researchers have published a review article in the journal Aging Male that implicates folic acid as a contributing factor in erectile dysfunction.

TherapeuticsMD announced it has received FDA approval for IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia.

Tofacitinib is the first and only Janus kinase inhibitor approved by the FDA for this patient population.

Screening for colorectal cancer (CRC) should begin at age 45 for people of average risk, according to newly updated American Cancer Society guidelines.

Shingrix (Recombinant zoster vaccine) has been associated with vaccine administration errors since it hit the market, according to a new CDC report.

One lot of TAYTULLA Softgel capsules sample packs (1 mg/20mcg, 6x28 size) has been voluntarily recalled by Allergan.

A study compares changes in medication regimen complexity in patients with uncontrolled T2D who were referred to a collaborative pharmacist-endocrinologist.

An Interview with Dr. Hien Nguygen, a PGY-1 Resident at Penn Medicine Lancaster General Health who has a love for geriatric pharmacy

LifePlus has announced their product Lifeleaf, which is an noninvasive monitor for glucose, blood pressure, heart rate, respiration rate, and oxygen saturation. How can change the field of wearables?

The hepatitis C virus (HCV) guidelines for unique populations have recently been updated.

Allergic reaction points up weak science behind some companies that offer dermatological solutions.

In this clip, Nimit Jindal, a PharmD candidate at the Rutgers University Ernest Mario School of Pharmacy, shares his thoughts on Provider Status and how student pharmacists can advocate for it.

We talk to 5 more pharmacists with exciting side hustles

Interview well, get an offer, and end the employment intermission.

How can you engage patients to adapt healthy behaviors and be adherent? Motivational Interviewing may be the missing piece.

Learn why pharmacists are in a great position to join the fastest-growing area in health care: technology

Looking to differentiate your pharmacy? These easy strategies can help your patients and increase rapport and retention.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Novel enzyme therapy for adults with PKU, a rare genetic disease, has won approval from the agency.